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Bullous pemphigoid (BP) and epidermolysis bullosa 
acquisita (EBA) are chronic blistering diseases associ-
ated with circulating complement (C)-binding anti -base-
ment membrane zone (BMZ) antibodies and tissue-de-
posited immune complexes at the BMZ. Experimental 
evidence supporting a role for C-activating immune 
complexes in the pathogenesis of dermal inflammation 
and blisters has been reported in BP but not in EBA. In 
this study tissue-deposited immune complexes composed 
of EBA or BP antibodies were tested for generation of 
C -dependent chemotactic activity and the capacity to 
cause dermal leukocyte infiltration and dermal-epider-
mal separation (DES). Chemotactic activity was meas-
ured by the leukocyte attachment (LA) method. The 
capacity of complexes to m ediate leukocyte infiltration 
a nd DES was examined in vitro using a newly described 
organ culture method. The results of LA showed immune 
complexes formed in vivo in EBA skin or in vitro by 
treating normal human skin with EBA antibodies were 
s ignificantly more active in mediating C -dependent 
chemotaxis than complexes in BP skin or those formed 
with BP antibodies of equivalent or higher C-binding 
titers. Furthermore EBA antibodies and C caused leu-
kocyte infiltration and DES in organ culture while BP 
antibodies did not . These results support a role for C-
binding anti-BMZ antibodies in the pathogenesis of EBA 
lesions and demonstrate differences in the capacity of 
BP and EBA immune complexes to generate C-depend-
ent chemotactic activity . These r esults suggest factors 
in addition to C-binding titers are important in the 
activation of C by BP and EBA immune complexes and 
suggest chemotactic factors othe r than those derived 
from C activation may be important in the recruitment 
o f leukocy tes in BP. 
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Abbreviat ions: 
BMZ: ba!;ement membrane zo ne 
BP: bu ll ous pemphi goid 
BPS: BP se ra 
C: complement 
DES: dermal -epidermal separation 
EBA: epidermoly!; is hullosa acqu isita 
EBA : EBA se ra 
GBSS: Gey's balanced salt solution containing '2 % bovine serum 
albumi n 
LA: leukocvte attachmenl 
I MEM: min-imal essenti al medium cont ai ning !) ~;, fetal calf se rum 
NHS: normal human se ra 
PB L: peripheral blood leu kocyle(s) 
PBS: 0.01 M Na~HP04' 0.0] M Na H"PO,., pH 7.2 
TCM: ti !;sue culture med ia 
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Bullous pemphigoid (BP) and epidermolysis bullosa acquisita 
(EBA) a re chronic blistering diseases characterized by ci rculat-
ing JgG and complement (C)-binding anti -Basement membrane 
zone (BMZ) antibodies, linear deposits of IgG and C compo-
nents at t he BMZ, subepidermal blisters, and inflammation in 
t he upper dermis [1,2]. These features suggest ant i-BMZ anti-
body-mediated C activation may playa role in t he pathogenesis 
of in!1ammation and derma l-epidermal separation (DES) in 
both diseases. Experimental evidence supporting a role for C 
activation in the pathogenesis of BP has been published but 
studies in EBA have not been reported [1] . 
One mechanism whereby C activation may contribute to 
inflammat ion is t hrough production of chemotactic factor, 
mainly C5a and recrui tment of leukocytes [3]. In experimental 
in!lammation, C- mediated recrui tment of leukocytes is usually 
assoc iated wi th an influx of neutrop hil gran ulocytes. 
Although C activat ion may cont ribute to inflammation in 
BP, the predominan t granulocyte in lesions is usually t he 
eosinophi l [4]. This suggests t.hat chemotactic factors other 
t han, or in addition to, t hose derived from C activation may be 
responsible for leukocyte recruitmen t. Recently, we encoun -
tered severa l patients with EBA early in the course of t hei r 
disease in whom t he histology was characte rized by a predom -
inance of neutrophils.* Furthermore, t hese patien ts had a high 
incidence of circulati ng C-binding IgG anti-BMZ antibodies. 
The histology in t hese cases suggested t hat C-dependent re-
cruitment of leukocytes might be involved in in!lam mation and 
that t here might be differences in the abi li ty of BP and EBA 
immune complexes to generate C-derived chemotactic factors. 
In this study, we have examined that question by comparing 
the ability of BP and EBA immune complexes deposited in 
vivo in peril esiona l skin and formed in vitro wi t h C-binding 
BP and EBA antibodies to mediate Codependent leukocyte 
migration in cryostat skin sections. In additi on ~ we examined 
the ability of C-binding BP and EBA ant Ibodies to mediate 
leukocyte migration and DES in human skin organ culture. 
The results provide support for immune complex and C-me-
diated inflammation in EBA and suggest EBA immune com-
plexes fo rmed in vivo and in vit ro possess greate r potent ia l for 
activating C than do BP immune complexes. 
MATERIALS AND METHODS 
Sera and JgG Fractions 
BP se ra (BPS) and EBA sera (EBAS) were obt.a ined from patients 
with acti ve disease. The 4 BPS were obtained from patient.s wit h 
clini ca l and histologic inflammation. EBAS 1- 3 were obtained from 
patients with clinical and histologic inflammation. All patients were 
diagnosed by clinica l, hi st.o logic, immunohistologic, and immunou lt.ra-
structural criteria 12]. EBAS were shown by previously reported im-
munochemica l method!; t.o contain antibodies react.ive with EBA ant.i -
gen 1;'1. IgG fract.ions of EBAS 1 and 2 were prepared by sequential 
ion exchan ge and affin ity chromatography on diethylaminoethyl 
* Gammon WR, Brigga man RA , Woodley DT: Epidermolysis bullosa 
acquisita presenting with feat.ures of bullous and benign mucous mem-
brane pemphigoid. Submi t.ted for publi ca ti on. 
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(DEAE). Sep hacel, a nd protein A Sep lwrose (Pharmacia, Inc. Pisca-
taway, New J ersey) using establi shed methods [6,7J. IgG fract.ion s were 
concentrated hy ultrafiltration and diluted 10 mg/ml in 0.15 M NaCI 
buffered with 0.01 M Na2HPO." 0.01 M NaH 2PO" pH 7.2 (PBS). 
Analysis of fractions by immunodiffusion aga inst s heep a n t.ihuma n 
serum and antihuman IgG showed a s ingle line of ident ity . T here were 
4 BPS (BPS 1- 4), 5 EBAS (EBAS 1- 5), and 2 EBA IgG fractions 
(prepared from EBAS 1 and 2) used in this ~LlIdy. IgG a nd C-hinding 
t iters of anti-BMZ a ntibod ies were determined using normal human 
skin as substrate a nd previously described methods [8J. Ant ibody tiLers 
In bu llous dIsease se ra, IgG fractions, a nd norm al huma n control se ra 
a re show n in Table I. No rma l human se ra (NHS) we re obtain ed from 
hea lthy adul t voluntee rs. Bullous disease a nd Nl-f S we re heat- inacti-
vated at 56' C fo r 30 min to destroy C activity. Platelet-poor fresh-
frozen NHS from a blood group type Rh -pos i ti ~e donor was prepa red 
as previously descr ibed and used as a source of se rum complement [()). 
All sera and IgG fractions were a liquoted and sto red frozen at -70' C. 
Shin 
Per iles ional skin was obtained by 4-mm punch biopsy under local 
1% Xylocaine a nesthesia from 4 BP patient.s wit. h eosinop hilic inflam-
mat ion and :3 EBA patient.s wit.h neutroph ilic infl ammation. Sk in was 
snap-frozen in liquid nitrogen, mounted in O.C.T. compound (M iles 
Lab. Inc. , Naperville, Illinois), a nd stored frozen at -70'C. No rmal 
huma n foreskin was obt.ai ned fresh from healthy neonat.es immediately 
afte r circumcision , trimmed of excess fat, a nd mounted on a corkboa rd. 
The epidermis and upper portion of the dermis was removed with a 
Castruviejo keratome set at, 0.4 mm. Keratomed skin was r insed 3 t imes 
in minima l esse nt ial medium conta ining 5% calf serum , MEM (G ibco 
Lahs, Gra nd lsI and, New Yo rk ) a nd immedia t.ely used for organ culture 
~tudies . 
P",.ipherol Blood Leukocytes 
No rma l human periphera l blood leukocyt.es (PBL) were obta ined by 
dextran sed Ime ntatIon of hepann lzed blood using a prev iously de-
sertbed method [6J. Cell viab ili ty was greate r t han 98% by t rypan blue 
exclUS Ion. Cells were coun t.ed In a hemocytometer and suspended in 
Geys' balanced salt solution cont.a inin g 2% bovine serum album in 
(a~SS (Flow Labs, McLean, Virgin ia. ) PBL suspensions co ntained 70~ 
80% granu locytes and 20- 30% mononuclear ce lls. 
[mmuno!luore,cence Method.~ 
Direct immunofluorescence for IgG and the third component of C 
(C.'l) a nd indirec t IgG a nd C3-hinding immunofluorescence was per-
formed using prev iously repo rted methods l8]. Immunoreagents pur-
chased from Cappel Labs, Cochranville, Pennsylva nia, included flu o-
resce in isothi ocyanate (F ITC)-conjugated IgG frac tions of goat, a ntisera 
to huma n IgG and human C.3 . Mo la r lluoresce in to prutein rat ios a nd 
antibody concent rations were: a ntihuman IgG (2.8 a nd 3.0 mg/m l); 
a ntIhuman C3 (:1.0 and 3.4 mg/ ml) . Co njugates were used at a dilu t ion 
of 1: 1 0- 1:20 in PBS co nta ining 0.2% NaN". 
TABLE I. Anti-BMZ antibody lilers in sera and /gG !raction..~ 
C:1 bindin g BPS 
BPS! 
BPS l 
BPS:! 
BPS! 
C l binding EBAS 
EBAS I 
EBAS2 
ERAS:! 
No n-C:3 binding EBAS 
E 8AS.! 
ERAS" 
C3 binding EBA IgG fract ions 
EBA Ige! 
EBA IgG 2 
Co nt.rol Sera 
N1-f S! 
NHS, 
IgG anti-BMZ an ti - C'·binding al1l.i -BMZ 
hody LiLer ant.ibody til er 
J2RO 320 
12RO 320 
1280 640 
2560 640 
320 IGO 
320 160 
160 80 
)60 0 
80 0 
640 :~20 
:320 160 
Negative 1:10 Negati ve LI0 
Negative 1:10 Negat ive 1:10 
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Leukocyte Al/.achmenl Assays 
Direct and indirect leuk ocyt.e att.ac hment. (LA) assays on cryostat 
sections of bullous disease skin and norma l huma n skin t reated with 
bullous disease a nti -BMZ antibodies were performeciusin g prev iously 
deSCrIbed methods l6,9]. Complement-dependent LA assays were per-
formed using PBL suspended in 10% fresh N HS. C- independent assays 
were performed usin g PBL suspended in 10% heat-inactivated N HS. 
All assays were performed in duplicat.e or triplicate. LA was quant. itated 
by coun t in g the number of PBL attached to t.he BMZ per mm BMZ. A 
mean LA was det.ermined by averaging LA values in 4- 6 skin sect. ions. 
Statist.ical analys is of results was performed by I-test. of the difference 
bel ween means of paired samples. 
Organ Cu.ltu.re 
Culture of skin with bu llous disease sera was performed usin" a 
modifica tion of a previously desc ribed met hod [101. Pieces of freshly 
kerat.omed foreskin (0.4 mm thick) were trimmed to 1.0 X 1.0 cm2 with 
a razor blade and washed in st.e rile MEM conta inin" 100 units of 
penici llin and 100 mg streptomycin su lfate/ml , t issue "culture media 
(T CM) . Skin was placed epidermis s ide up on a 12.0 mm -dia meter 5.0 
wpore size ni t roce llulose disc (Mi llipore Corp. , Bedford, Massa~ lllI ­
setts), moistened with T CM a nd fl oated on 1.0 1111 of T CM cont.a inin u 
25 % heat.- inactivated B PS, EBAS, NHS, or IgG frac tion of EBAS. 
Cultures were performed in Limbro 35.0-ml t issue cul ture wells (Flow 
~aboratones) for 18 h at a2'C in a humidified 5% CO 2-a ir atmosphere. 
~I<tn was t hen removed, washed twice in TCM, and cut int.o ) x 10 
mm strips wit h a ~azor blade. One strip from the ce nte r of each piece 
of s kill was qll1ck- froze n In lIqUId nIt rogen a nd processed for direct I"G 
a nd indirect C3- binding immunofluoresce nce. Rema ining st rips w: re 
cult.ured separately and in tripli cate in 0.5-m l sterile polyp ropylene 
tu~)es (BrInkm an Instrument.s Inc., W est.bury, New York) co nta ining 
0 .. ) ml of: (1) 40 x 10" PBL/ml a nd 25'Y" fresh NHS in GBSS; (2) 40 X 
10" PBL/m l and 25% heat-inactivated NHS, or (3) 25 % fresh NHS 
se rum alone. Tubes were sealed a nd incubated 4 h at 37' C with "ent le 
end -over-end rotat.ion . T issue s trips were t.hen washed in PBS and 
either quick -froze n in liquid nitrogen or fi xed in formalin . Froze n tissue 
was processed for d irect. 19G and C3 immun ofluorescence a nd fi xed 
t issue for routine H & E histology. 
There were a tota l of 34 skin s trips treated with 4 C- binding BPS. 
T welve were subsequent ly treated wit h PBL in fresh NH S, 12 with 
PBL in inactivated NHS, and 10 with fresh NHS a lone. T here were 26 
strips t reated with 3 C3-binding EBAS. N ine we re t reated with PBL 
in fr_esh N HS, 9 wit.h PBL in heat.- inact,ivated N HS, and 8 wit.h fresh 
N HS a lone. There were 16 strips t.reat.ed wit.h eit.her of the 2 EBA IO"G 
fractions. S ix were subsequently treated with PBL in fresh NHS~ 4 
WIth PB L III heat.-lIlactlvated N HS, and6 with fresh NHS a lone. There 
were 17 strips of skin t. reated wit h either of' t.he 2 non-C- binding EBAS. 
SIX were subsequently t.reated with PBL in fresh NHS, G with PBL in 
1Il8ctlvat.ed Nl-fS , a nd 5 wit h fresh NHS alone. There were Hi strips 
treated wlt.h cont.rol N HS dUrIng t.he init.ia l incubat.ion. S ix were 
subsequently t reated with PBL in inactivated NHS, 6 with PBL in 
fresh Nt:S, and 4 with fresh N HS alone. T en t.o twent.y 4 I'm -thick 
secyons f rom each strip were examined by H & E t.o evaluate leukocyte 
IIlfti tratlOn to t.he BMZ a nd DES. 
RESULTS 
Direct LA in BP and EBA Skin 
The results o f direct LA in BP a nd EBA s kin are s h ow n in 
Tab le II. C-~ependent LA in eac h of t he 3 EBA biops ies was 
g reater than lJ1 a ny oj t he 4 BP bi opsief; . Wh en t h e averaue LA 
fo r t he 3 EBA biopsies (204 ± 24 PBL/mm BMZ) was com~)ared 
t? t he. average 111 t he 4 BP biopsies (50 ± 5), the differe nce was 
s lgJ1lftca nt (p < 0.00l). A comparison o f LA amana EBA and 
BP biopsies s howed there wa s n o s ignifi cant differ:nce within 
each group. Whe~ C- inclependent LA assays wer e perform ed, 
there was a s lglllficant decrease in LA in EBA bi ops ies (204 to 
48) a nd in BP biopsies (50 to 27) . These res ul ts s UUCTest the 
diffe re nces in LA between t he two groups are l arg;l~ C-de-
pendent. 
In.direct LA 
. 1 ndir~ct LA was p e rform ed s imul tan eously on cryostat sec-
tions o f norma l hum a n s kin t reated wi t h eac h o f 4 BPS a nd 3 
EBAS dilu ted 1.:5, 1:10, 1:20, or 1:40. The results comparing 
the m ea n LA o f t hree EBAS with 4 BPS a re s hown in Table 
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TABLE II. Direcl leuhocyte attachment in SP and EBA shin 
Leukocyte attachm ent Leukocyte attach-
BP hi - ment EBA hiop~y # 
W"/com- Wo'/com- opsy # W /com- Wo/com-
plemcnl plcmenl plcment plemenl 
1 213 ± 21" 64 ± 6 48 ± 6 26 ± 3 
2 175 ± 18 72 ± 8 2 32 ± 4 18 ± 6 
:3 225 ± 32 49 ± 12 3 62 ± 2 34 ± <\ 
4 58 ± 9 31 ± 4 
Ave rage 204 ± 24 !i8 ± 9 50 ± 5 27 ± 4 
le ukocyte 
attachme nt" 
a W = Wi t h. 
b W o = Without. 
c Standa rd deviation. 
d Average le ukocyte a tt ac hme nt in :3 EBA a nd 4 BP biops ies. 
TABLE Ill. indireclleulwcyle attachment using complemeni. bin.ding 
BP and EBA anli-BMZ an libodies 
Leukocyte a\tHchmenl (PBL/ mm BMZ) 
Seru m With complemen t Without complement 
t ite r EBAS BPS (p) EBAS BPS (p) 
]:.5 171 ± 19 120 ± 30 0'()2 5:3 ± 7 38 ± 12 0.1 
1: 10 156 ± 8 92 ± 22 0.001 5 1 ± 12 46 ± 8 0.1 
1:20 13:3 ± 27 75 ± 32 0.02 38 ± 16 42 ± J4 0.1 
1:40 134 ± 16 72 ± 14 0.001 4:3 ± 10 52 ± 2 1 0.1 
III. The results of a representat ive experiment are shown in 
Fig 1. When the assay was performed in t he presence of serum 
C, a ll 3 EBAS ::; howed greater LA than any of the 4 BPS at 
equivalent se rum dilut ions. When dilutions of EBAS a nd BPS 
were adjusted to provide equivalent C-binding anti-BMZ anti -
body t iters, the differences were even greater (results not 
show n). ln the absence of a C source, there was no signifi cant 
difference in LA mediated by BP or EBA se ra at any of the 4 
d ilutions. These results show significantly greater Codependent 
LA by immune complexes prepared in vitro with EBAS even 
though C-binding anti-BMZ antibody titers were less than 
t hose in BPS. 
Results of Immunofluorescence in Cu.ltured S hin 
Representative strips of skin were examined by direct IgG 
a nd indirect C3-binding immunofluorescence following the in-
itial 18-h incubation with bullous disease se ra or IgG fractions. 
S kin strips were aga in examined following a 4-h incubatio n 
wit h PBL and NHS by direct IgG and C3 immunof1u orescence. 
Following the ini t ial incubat ion, linear fgG deposits were ob-
served at the BMZ in a ll sec tions treated with BPS and EBAS 
and EBA IgG fractions containing C3-binding anli -BMZ anti-
bodies . IgG deposits were seen in sections treated with on ly 1 
of 2 EBAS containing non-Cl-binding ant i-B MZ antibodies. 
By indirect C3-binding immunofluorescence, a ll sections 
treated with C3- binding anti- BMZ ant ibodies showed linear C3 
deposits at the BMZ. Following the 4-h incubation with PBL 
a nd fresh NHS, sections that had received t reatment with C3-
binding anti-BMZ antibodies continued to show linear IgG 
deposits at t he BMZ but in addition showed C3 deposits. 
Sections t hat received t.reatment with C3-binding anti-BMZ 
a nt ibodies and then PRL in heat-in activated NHS showed 19G 
but no C3 deposits (Table IV). These results show that both 
C3-binding EBA and BP anti -BMZ antibodies bind to the 
B MZ in cultured skin and that these antibodies can mediate 
C3 depos ition during a 4- h incubat. ion with fresh serum. 
Results of Histologic Examination of Cultured Shin 
The resu lts of histo logic examinat ion of skin cul tured first 
wit h antibodies and subsequent ly with eit her PBL in fresh 
NHS or PBL in inactivated NHS are shown in Table V. Most 
sections cul tured with C3- binding EBAS or IgG fractio ns, PBL, 
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and fresh NHS showed leukocytes (mainly neutrophil s) infil-
trating the upper dermis and t he BMZ (Fig 2). In t.he majorit.y 
of these sections, foci of vacuolization or microvesiculation at 
the BMZ were noted. Foci of microvesiculation varied in length 
from several hundred microns to over a millimeter a long t he 
BMZ. In several sections the epiderm is was completely lost and 
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FIG 1. Compa ri son of LA between BPS, (0--- 0 ) a nd EBAS, 
(e.----e) at dilu t ions o f 1:5- 1:80. C3-binding t ite rs of BPS, and EBAS, 
were L~20 and 1:160, respective ly. 
TABLE I V. Re:;ults of immunoflu orescence in skin cultured with anti-
BMZ antibodies, leukocytes, nn.d N HS 
PBL and fresh PB L and inact.i -
Ant ibody t reat ment. Serum # NHS vilted NHS 
IgG C~l 19-G C:l 
C3 binding BPS, + + + 
BP sera BPS. + + + 
BPS" + + + 
BPS, + + + 
C8 binding EBAS, + + + 
EBA se ra EBAS2 + + + 
EBAS:1 + + + 
C:3 bindin~ EBAS, + + + 
EBA IgG EBAS'l + + + 
Non -C3 binding EBAS, + + 
EBA sera EBAS" 
Controls NHS, NO NO NO NO 
N]'IS2 NO NO NO NO 
TABLE V. Effect of anti-BMZ Gntibody on leuhocYle infillra/ion an.d 
dermal-epidermal separation ill skin organ culture 
P8 L + fresh serum PBL + inact ivatcd serum 
Ant.ibody # Spec- LI" DES' # Spec- L! DES 
treatment imens (% (% imens ("n (0' I e 
exam- speci - speci- exa m - speci- speci -
ill cd mens) mens) incd mens) mens) 
C3 binding 12 17 0 12 0 0 
BP sera 
C3 binding 9 89 67 9 12 0 
EBA sera 
C3 binding 6 83 8" ,j 5 20 0 
EBA 19G 
Non-C3 binding 6 0 0 6 0 0 
EBA se ra 
N HS 6 0 0 6 0 0 
" LI = leukocyte infil t rat ion to t.he BMZ. 
" DES = Dermal-epiderma l separation. 
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. / tt: -, 
" FtG 2. a, Histology of sk ill cultured with C3-binding BPS, PBL, a nd fresh N HS. No leukocyte infil t ration o r DES was see n (x 250). b, 
HisLOlogy of sk in cu ltu red wit.h C3-hi ndin g EBAS, PBL, a nd fresh N HS. Leukocytes a re present in the upper dermi s and at the BMZ. Multiple 
foci of dermal vacuolization (ar raws) are prese nt just beneath t he BMZ (x 500). c, Culture condi t ions same as (b). Note mic roves icle (arrow) at 
HMZ Ii lied with leukocytes (x 4(0). d , Cu lt ure condi tions same as (b) . Note a lmost complete DES and leu kocytes inli lt ra ting the BM Z (x 400). 
the upper dermis reveal ed numerous neutrophils. When EBA-
treated strips were incubated with PBL a nd inactivated NBS, 
there was a signi fica nt reduction in t he percentage of sections 
showing leukocyte infil t rat.ion and none showed DES. Com-
pared to EBA treated skin, t here was little leukocyte infil tration 
and no DES in fl kin treated with BPS even t hough C-binding 
t ite rs of t hose se ra we re greater t han t hose in EBAS. No 
leu kocyte infil t ration or DES was seen in sk in initi a lly treated 
with contro l human sera nor in skin which was not treated 
with leukocytes. 
DISCUSSION 
A ro le for C-aetivating anti-BMZ a ntibodies in t he pathoge n-
esis o f' BP les ions has previously been proposed a nd supported 
by a number of obse rvations and experimental studies. These 
have ineluded: deposits of 19G and C at t he BMZ; cireulating 
C-binding anti-BMZ antibod ies; ev idenee for C aet.ivation a nd 
C5a ehemotaetic factor in bli ste r fluids ; a nd passive transfer of 
the immu nologic and hi sto logic features of BP in a nima ls with 
C-binding BP a nt ibod ies [11- 16J. Us ing LA assays, it was 
prev iously shown t hat immune complexes form ed in vivo in 
peril esional BP skin and in vitro by t reating norm al human 
skin with C-hind ing BP ant ibodies eould aetivate se rum C at 
the BMZ and generate C-deri ved ehemotactie activity, presum -
ably C5a [6,9,17J. Furthermore, it was shown t hat leukocytes 
ree ru ited to t he BMZ of skin sections could cause BMZ injury 
a nd DES [18J. 
In t his study LA assays have shown t hat EBA immune 
complexes formed in vivo and in vitro are a lso capable of 
activati ng C a nd mediating t he attaehmenL of leukocytes to the 
BMZ. A requirement for C in t hese studies was demonstrated 
by t he sign ificant drop in LA in t he abse nce of fresh serum a nd 
when dilu t ions of EBAS in excess of C- binding titers were used. 
These studies show t hat EBA ant ibod ies form functional im -
mune complexes in vit.ro a nd more importantly t hat EBA 
immune complexes present in vivo are potentia lly capable of 
aetivating C and recrui t ing leukocytes to the BMZ. 
In addition, EBA sera a nd IgG fractions con ta ining C-bind-
ing anti-BMZ ant ibodi es could se n. ·it ize viable human skin in 
vitro and mediate both t he C-dependent infil tration of leuko-
eytes to t he B MZ and DES in orga n cu lture. Ev idenee t hat 
EBA an t i-BMZ a ntibodies were responsible for C activation 
was supported by the resu lts of immunonuoreseence showing 
IgG and C3 deposited a long the BMZ. A role for a ntibodi es in 
C act.ivation was further supported by the findin g that EBA 
IgG fractions were just as effective as EBAS in mediating 
leukocyte infil t ration. Leukocyte infil t ration to t he BMZ was 
presumably dependent on C-derived chemotactic facto rs inee 
infil t ration requ ired both C-binding EBA an t ibodies a nd fresh 
se rum. DES appea red to depend on leukocyte infil t ra tion s ince 
it was never observed in seetions in which leukocytes had not 
inlil trated to t he BMZ. The mechanism of leukocyte-mediated 
DES was not determ ined, but was p resumably due to leukocyte-
derived proteases, reactive oxygen intermediates, or both. 
These cells are known to produee or release both sets of 
mediators when stimulated by immune complexes. Evidence 
t hat reactive oxygen intermediates can cause DES has not been 
reported bu t there is evidence t hat leukocyte proteases can 
[19]. 
Previous aut hors have demonstrated BP antibody a nd C 
binding to the BMZ using a simila r t issue culture syst.em; 
however, to our knowledge, t his is t he first successful t ransfer 
of both histologic a nd immunologic features of a subepidermal 
bu llous disease in organ cul ture [10,16 J. These studies provide 
the first experimenta l ev idenee supportin g a role for C-activat-
ing a nt i-BMZ an t ibod ies in t he pathogenes is of EBA lesions. 
An unexpected findin g in th is study was the significant ly 
greater aetivi ty ofEBA complexes t ha n BP complexes in assay 
requir ing C activation . In t he direet and indireet LA assays and 
in orga n eulture, immune eom plexes formed wi th EBA anti-
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bodies we re s ignifican t ly m ore act ive in recrui t in g leuk ocytes 
t han t h ose formed with BP a n t ibodies. The greater activi ty of 
EBA complexes formed in v it ro was particu lar ly surpri s ing 
si n ce t iters o f C-bi ndin g anti -BM2 a n t ibodies in EBAS and 
IgG fractions were 2-3 doubling dilutio ns less t ha n t hose in 
BPS. These resul ts show t hat C activat ion by different a n t i-
BM2 a n t ibodies m ay vary independent of C- binding t ite rs a nd 
s u ggest that othe r facto rs a re impo rta n t in determining t he C-
activating potentia l o f co mplexes formed by t hese antibod ies . 
In o rga n culture, BPS conta ining C- binding a nti-BMZ a n t i-
body t ite rs as hi gh as 1:640 we re re lat ive ly ineffective in me-
diating leuk ocyte infil trat io n . This did not appea r t o be due to 
t h e abse nce o f C-binding immune complex fo rmation in t issue 
s ince IgG a nd C3 deposits we re observed at t he BMZ fo llowing 
incubation of BP t reated section s with PBL a nd fres h N H S. 
H owever , it is poss ible that re lative to EBA , fewer BP immune 
complexes were fo rmed a nd activated less C. BP complexes a re 
for m ed within the lam in a luc ida which is located between t he 
la mina densa (basa l la mina) a nd basal ce ll p lasma m embra n e. 
EBA compl exes are located in t he upper de rmis beneat h the 
la mina de nsa o r b eneath t he la min a densa-a nc horing fibril 
zo n e [2]. Assuming anti-B MZ antibodies diffu sed t hrough t he 
dermis to reac h t he ir anti ge n , BP a n t ibodies wou ld have to 
t ravel further a nd p ass t hrough t he lam in a densa. The la mina 
d e nsa could, as has bee n suggested, ad as a p hysioc he mica l 
barrier whic h might retard diffus ion of BP a n ti bodies a nd li mit 
their access to a n t igen [20 ]. Howeve r, great e r diffu ion distance 
a nd permea bi li ty barrie rs would not exp la in why EBA com -
plexes were m ore potent in leukocyte recruitmen t in the indi -
rect LA assay. In t hat assay, both BP a nd EBA a ntibodies 
s hould have direct access to t he ir respective a n t ige ns in c ryostat 
s kin sections. An addit ion a l reason for t he a pparently greater 
activity o f EBA immune co mplexes m ay be that t he re is a 
higher de ns ity o f EBA complexes fo rmed at the BMZ. Al t hough 
t h e re lative amounts of BP a nd EBA a n t ige n in skin have not 
been qua nti tated , immunoul t rastructura l studi es suggest EBA 
a ntigen s occupy a la rge r po r t ion of t h e BMZ. Whereas BP 
a n t igen is located wit hin a 20-30 nm -wide lamina luc ida, EBA 
a n t igen m ay occu py a n area several hundred nanometers wide 
beneath t he la mina densa [2] . Othe r fac tors affecting amounts 
o f co mplexes formed or t he a mounts of C activated cou ld 
incl ude t he relative a m ounts of antigen s ava il a ble to form 
complexes a nd t he proper t ies of t h e co mplexes t hemse lves t hat 
affect C activation a nd regul atio n. It is unlike ly t hat t hese 
properties ca n be dete rmin ed until t h e com plexes can be pre-
pared in re latively pure fo rm a nd stud ied in v itro. 
The resul ts of t hi s study may be re leva nt t o understandin g 
t h e m ec hani s ms whereby infla mmation is initia ted in BP a nd 
EBA and t h e diffe re nces we h ave obse rved in t he types o f 
inflammation in eac h disease. M ost BP lesion s a re cha racte r -
ized by a predomina nce of eO!'> inop hil s a nd re lative ly few n eu -
t rophils in the upper derm is [4,21). In t he cases o f EBA whose 
t issues a nd se ra were used in this study, n eutrop hil s we re a 
promine nt compone nt of the infl a mmato ry infiltrate a n d, in 
some cases, th e o nly gra nulocyte see n . S in ce neutrop hil s are 
more cha racteristic o f C- m ediated infl a mm atio n , C-dependent 
cell rec ruitme nt may playa great e r ro le in t he deve lopmen t of 
inf1a mmat io n in EBA t ha n in BP. The findin gs in t his study 
would support that hypothes is. In t his rega rd, it. is of inte rest 
t hat the on ly other disease in which we have o bse rved direct 
LA leve ls as g reat as t hose in EBA s kin was in a form of bullous 
systemic lupus e ryth ematosus which is al so cha racte rized by 
neutrophil -predom ine n t inflammat ion [22 ]. 
It is importa nt to note that the findin gs in t hi s s tudy m ay 
not be releva nt to a ll EBA lesion s . Many p atients have been 
desc ribed with m a rked s kin fragili ty a nd DES unassoc iated 
w it h s ignifican t inf1a mmation [23-25). M ost of t hese patients 
have been seen re lat ively late in their disease and in very few 
have c irculating C-binding a n t i-BM2 a ntibodies been present. 
S uch cases would suggest t hat mec hanis ms othe r t ha n C-
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mediated infla mmation may be in vo lved in t h e pat.hogenesis of 
EBA lesions. 
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